• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Dermatology Practice Deploys ZeroEyes AI-Based Gun Detection

by Jasmine Pennic 09/10/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– ZeroEyes, a leader in AI-based gun detection technology, announced today the deployment of its solution at Lane Dermatology & Dermatologic Surgery. 

– This marks the first private healthcare practice to adopt ZeroEyes’ proactive security technology.

Addressing Growing Security Threats

With the rise of gun-related violence in the United States, healthcare facilities face increasing security challenges. While maintaining an open-door policy for patients and visitors is essential, it also increases the risk of violence. Lane Dermatology & Dermatologic Surgery is taking proactive steps to address these threats by implementing ZeroEyes’ AI gun detection and intelligent situational awareness software.

How ZeroEyes Works

ZeroEyes’ technology is layered on existing digital security cameras. If a gun is detected, images are immediately shared with the ZeroEyes Operations Center (ZOC), a 24/7/365 operation staffed by trained veterans. If the threat is confirmed, alerts and actionable intelligence are sent to law enforcement and local staff within 3 to 5 seconds.

ZeroEyes’ AI gun detection solution offers a valuable tool for healthcare facilities to proactively address security threats. By implementing this technology, Lane Dermatology & Dermatologic Surgery is setting a new standard for safety and security in the healthcare industry.

“Private healthcare practices often face significant financial constraints when it comes to implementing security measures,” said Mike Lahiff, CEO and co-founder of ZeroEyes. “ZeroEyes serves as a valuable force multiplier, allowing facilities to reduce costs on security personnel while maintaining effective monitoring. Lane Dermatology & Dermatologic Surgery has demonstrated a forward-thinking approach to healthcare security, and we hope other facilities will follow their lead.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |